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Background: Lead is a neurotoxic metal that crosses the placenta 
freely. It has adverse effects on a range of birth outcomes. The few 
studies reporting on the associations of prenatal exposure to lead and 
child growth have had conflicting results. This study aimed to examine 
the effect of low-level prenatal exposure to lead on children’s growth 
from 4 to 61 months old. 
Methods: Pregnant women were enrolled in the UK Avon 
Longitudinal Study of Parents and Children (ALSPAC). Whole blood 
samples for pregnancies with a live birth were analysed for lead 
(n=4140). A 10% subsample of the offspring cohort (Children in Focus) 
were invited to clinics at 10 time points (4–61 months) at which 
anthropometric measurements were carried out; z-scores for height, 
weight and BMI were calculated using the 1990 British Growth 
Reference Standards. Associations between prenatal log10-lead 
concentrations and z-scores and other anthropometric measures 
were modelled using adjusted linear regression models in an imputed 
dataset for children who attended at least one clinic (n=574). 
Results: The mean prenatal blood lead concentration was 3.59±1.50 
(range 1.22–14.70) µg/dl. There was no evidence for any associations 
of low-level prenatal lead exposure with z-scores for BMI, height or 
weight in adjusted models from age 4 to 61 months. There were no 
associations for other anthropometric measures including mid-upper 
arm circumference, head circumference and waist circumference. 
There was some evidence for a weakly positive effect of prenatal lead 
exposure on head circumference in girls at age 43 and 61 months (at 
61 months unstandardised B coefficient 1.59 (95% CI 0.12, 3.16) cm, 
p=0.048) but not at other ages. 
Conclusions: There was no consistent evidence of associations 
between prenatal exposure to lead and measures of growth and 
anthropometry from age 4 to 61 months in this cohort of children in 
the UK.
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Introduction
Lead is a neurotoxic metal that is widespread in the 
environment. Many countries have adopted lead abatement 
measures in recent years, including the removal of lead from 
paint and petrol, resulting in declines in lead levels in children 
and adults1,2. Common sources of exposure still include water, 
diet, dust and soil3, and smoking4. Lead is still a public health 
concern, however, even in countries where exposure is relatively 
low: there is increasing awareness that adverse effects occur 
at all levels of lead exposure, with no lower limit for effects5–7.
Pregnancy is a critical time for exposure to lead for the mother 
and fetus. Once absorbed from the gastrointestinal tract or the 
respiratory system, lead is transported bound to erythrocytes 
and accumulates in bone (with a half-life of approximately 
30 years). An increased demand for calcium means that 
maternal turnover of bone increases during pregnancy8 and bone 
becomes the main source of lead in the blood9. Lead crosses 
the placenta freely10,11 and can have adverse effects on a 
range of birth outcomes, including low birth weight and 
small-for-gestational-age, across a range of maternal blood 
lead levels7,12–14. In accordance with the theory of the develop-
mental origins of health and disease, constraints on fetal growth 
are likely to have a long-lasting effect on postnatal growth15, 
and thus on child health and development. The potential mecha-
nisms for the adverse effect of prenatal lead exposure on growth 
are largely undefined, but may include direct interference 
with bone cell function and/or disruption of hormones (such 
as vitamin D and thyroid hormones) that are involved in 
the synthesis of the bone matrix, as well as epigenetic 
mechanisms.
There have been conflicting results among the few studies 
that tested the associations of prenatal exposure to lead and 
subsequent measures of child growth in both cross-sectional16–18 
and longitudinal19–28 analyses. Some have shown no associa-
tions despite relatively high16,24,26 or likely high20 maternal lead 
concentrations; some have shown transient adverse effects 
in children up to about 15 months of age29 or adverse effects 
in girls but not boys19,23. Others have suggested that pre-
natal lead exposure is associated with increased BMI in 
childhood17,21,25. These varied findings likely reflect differences 
in exposure levels, the measurement tissue chosen (e.g. mater-
nal blood, cord blood, maternal bone) and timing of sampling, 
differences in the length of time and the number of occasions 
that children are followed up, as well as children’s postnatal 
exposure to lead and other factors affecting growth.
To enable a clearer understanding of the association between 
prenatal lead exposure and growth trajectories, there is a need 
for further studies with longitudinal measures of growth. The 
Avon Longitudinal Study of Parents and Children (ALSPAC) 
is a birth cohort study in which prenatal lead exposure was 
measured as the mothers’ blood lead concentration (B-Pb) 
in the first trimester. The aim of this study was to evaluate 
associations of anthropometric measures in children aged 
between 4 and 61 months (z-scores for height, weight and BMI; 
head circumference, waist circumference and mid upper arm 




The sample was derived from ALSPAC, a population-based 
study investigating environmental and genetic influences on the 
health, behaviour and development of children. All pregnant 
women in the former Avon Health Authority with an expected 
delivery date between 1 April 1991 and 31 December 1992 were 
eligible for the study; 14,541 pregnant women were enrolled, 
resulting in a cohort of 14,062 live births30,31. Further details of 
ALSPAC are available at www.bris.ac.uk/alspac and the study 
website contains details of all the data that are available through 
a fully searchable data dictionary and variable search tool 
(http://www.bristol.ac.uk/alspac/researchers/our-data/). Ethical 
approval for the study was obtained from the ALSPAC Ethics 
and Law Committee and the Local Research Ethics Committee 
and conformed to the Declaration of Helsinki. Informed consent 
for the use of data collected via questionnaires and clinics was 
obtained from participants following the recommendations 
of the ALSPAC Ethics and Law Committee at the time.
Exposure measurement: collection, storage and 
analysis of blood samples
Whole blood samples were collected in acid-washed 
vacutainers (Becton and Dickinson, Oxford, UK) by mid-
wives who were collecting blood for clinical purposes with a 
vacutainer system. Samples were collected as early as possible 
in pregnancy (median of 11 weeks’ gestation (IQR 9–13 weeks) 
with a mode of 10 weeks). Whole blood samples were stored 
in the original tube at 4°C at the collection site before being 
transferred to the central Bristol laboratory within 1–4 days. 
Samples were kept at ambient temperature during transfer 
(up to 3 h). They were then stored at 4°C until analysis. Details 
of the analysis have been reported4,32. In brief, inductively cou-
pled plasma mass spectrometry in standard mode (R. Jones, 
Centers for Disease Control and Prevention (CDC), Bethesda, 
MD, USA CDC; Method 3009.1) was used to measure B-Pb 
with appropriate quality controls. The analyses were completed 
for 4285 women for lead. One sample had a lead level below 
the limit of detection: this was assigned a value of 0.7 times 
the lower limit of detection (limit of detection/√2)33,34. Of 
the 4285 mothers with a blood lead measurement during preg-
nancy, cases without a live birth and those who withdrew 
consent were excluded, leaving 4140 offspring for further 
analysis.
Outcome measurements
The Children in Focus (CiF) cohort, comprising about 10% of 
the ALSPAC cohort, was selected from the last 6 months of 
ALSPAC births, occurring from June to December 1992. 
Mothers who had moved away from the study area, were lost 
to follow up, or whose baby had died, or who had two or more 
pregnancies in the study were excluded. Very premature babies 
(<33 weeks) participating in the Avon Premature Infant Project 
and their full-term controls were also excluded. 1432 children 
were invited to and attended at least one of a series of ten 
Page 3 of 10
Wellcome Open Research 2020, 5:235 Last updated: 08 OCT 2020
clinics at 4, 8, 12, 18, 25, 31, 37, 43, 49 and 61 months. Of the 
1432 children, 574 had a prenatal B-Pb measurement. Clinic 
attendance rates are shown in Extended data, Supplementary 
Table 135.
Measures of weight and length or height were taken at each clinic, 
as were head circumference and MUAC. Waist circumference 
was measured from 31 months onwards. The equipment used 
for each type of measurement is shown in Extended data, 
Supplementary Table 235. BMI was derived as weight/height2.
Anthropometric measures for BMI, weight and height were con-
verted to z-scores using the British 1990 Growth Reference 
Data with adjustment for sex and age at clinic visit36,37.
Covariates
We considered the following variables to be potential confound-
ers of the relationship between prenatal lead exposure and 
offspring weight and height measures: maternal age (years), 
parity (n), education (None/Certificate of School Education/ 
Vocational/O Level/A Level/Degree), pre-pregnancy height and 
weight (from which BMI (kg/m2) was calculated), alcohol con-
sumption in the first trimester (measures of alcohol per day) 
and cigarette smoking in the first trimester (n per day). These 
variables were derived from four postal self-completion ques-
tionnaires the mothers received during pregnancy (http://www. 
bristol.ac.uk/alspac/researchers/questionnaires/; questionnaires 
13548, 12452, 13194 and 12423).
Statistical analysis
Main analyses. Analyses were carried out with IBM SPSS 
version 24 with the exception of z-scores, which were calcu-
lated in Stata (StataCorp, College Station, TX, USA) using the 
zanthro function.
We initially examined potential response bias in the sam-
ple by comparing the background characteristics of children 
enrolled in ALSPAC with a prenatal B-Pb measurement 
available to those without. We also compared the characteristics 
of children in ALSPAC-CiF that had a prenatal B-Pb measure 
with those without the measure. For all children with a prena-
tal B-Pb measure, we also compared the characteristics of those 
with complete data (exposure and all clinic measures) to those 
without complete data.
Multivariable linear regression modelling was used to examine 
the association of B-Pb with each outcome variable. B-Pb was 
log
10
-transformed to account for non-linearity in the variable. 
There were 137 cases with complete data on anthropometry and 
confounders: this was considered to have too little power to allow 
a complete case analysis. Analysis was therefore carried out 
on two datasets. (1) The first dataset was generated with mul-
tiple imputation by chained equation (MICE) applied to miss-
ing data for the 574 children with prenatal B-Pb included in 
ALSPAC-CiF. The patterns of missing data are shown in Extended 
data, Supplementary Table 335. We generated 25 datasets with 
200 iterations separating each imputed dataset. All outcomes and 
all confounders were imputed where missing (indicators used 
in the imputation were log
10
 prenatal B-Pb, birthweight, crown– 
heel length at birth, head circumference at birth and gestational 
age at birth). (2) The second dataset contained all available 
cases at each time point (n=275–374). The models for z-scores 
were adjusted for maternal age (years), maternal smoking (n per 
day), maternal education, parity, alcohol (n per day) and ges-
tational age at sampling (weeks). Models for MUAC, waist 
circumference and head circumference were also adjusted for 
sex and age at clinic visit (months). As an additional analysis, 
the term sex×log
10
 B-Pb was added to the models to test for 
interactions. Where interaction tests showed evidence of 
associations (p≤0.2), further adjusted regression analyses were 
done with stratification by sex.
Regression diagnostics (primarily plots of residuals) were 
used to check that the models fitted the observed data well, to 
test the assumptions of regression, and to identify any cases 
that had undue influence on the model. Results are reported as 
adjusted unstandardised B coefficients with 95% confidence 
intervals at each clinic age.
Sensitivity analysis. Sensitivity analyses were conducted to 
verify the statistical model assumptions and test the robustness 
of the findings: the adjusted multivariate linear regression analy-
ses were repeated after exclusion of children born preterm 




The characteristics of the children with and without a prena-
tal B-Pb measurement in ALSPAC were similar except that 
children with prenatal B-Pb had a greater maternal age and 
higher maternal educational attainment (Table 1). The charac-
teristics of children with and without complete data in ALSPAC 
and ALSPAC-CiF are shown in Extended data, Supplemen-
tary Table 435. Those with complete data in ALSPAC tended 
to include fewer mothers that smoked, mothers that were older 
and better educated, and fewer preterm babies than those with 
incomplete data. In ALSPAC-CiF, those with complete 
data tended to include mothers that were more likely to be 
older and better educated than those with incomplete data (data 
analyses were carried out on (1) an imputed ALSPAC-CiF 
database and (2) all available cases in ALSPAC-CiF).
Regression analyses
Anthropometric data at each age point are shown in Extended 
data, Supplementary Table 535 for the imputed dataset and 
for all available cases. There were no associations between 
log
10
 B-Pb and z-scores for weight, height or BMI at any clinic 
age for the imputed dataset or all available cases (Figure 1 and 
Extended data, Supplementary Figure 135). Similarly, there 
were no associations between log
10
 B-Pb and MUAC, waist 
circumference or head circumference in either dataset (Figure 1 
and Extended data, Supplementary Figure 135).
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Table 1. Characteristics of children enrolled in ALSPAC and in ALSPAC-CiF with or without a prenatal measurement of 
B-Pb.
Participants in ALSPAC (n=14,602 live 
births)
Participants in ALSPAC-CiF (n=1432 


















    Underweight (<18.5) 170 (4.8) 407 (5.1) 0.721 24 (4.6) 41 (5.5) 0.690
    Normal weight (18.5–24.9) 2611 (74.3) 60008 (74.6) 377 (71.5) 533 (71.7)
    Overweight/obese (≥25.0) 735 (20.9) 1638 (20.3) 126 (23.9) 169 (22.7)
Smoking
    No 3010 (79.2) 6713 (79.3) 0.884 458 (86.6) 651 (84.5) 0.308
    Yes 792 (20.8) 1754 (20.7) 71 (13.4) 119 (15.5)
Alcohol
    No 1880 (67.8) 2825 (68.4) 0.587 288 (66.5) 388 (65.0) 0.612
    Yes 893 (32.2) 1304 (31.6) 145 (33.5) 209 (35.0)
Parity
    0 1719 (44.4) 4083 (44.8) 0.704 255 (45.2) 378 (46.6) 0.609
    ≥1 21549 (55.6) 5030 (55.2) 309 (54.8) 433 (53.4)
Age (years)
    ≤25 1177 (28.4) 3134 (31.7) <0.001 113 (19.5) 216 (25.4) 0.026
    >25–30 1630 (39.4) 3886 (39.3) 249 (42.9) 350 (41.2)
    >30 1333 (32.2) 2874 (29.0) 218 (37.6) 283 (33.3)
Education
    None/CSE/Vocational/O levels 2306 (62.0) 5743 (65.9) <0.001 327 (57.9) 493 (61.8) 0.147
    A level/degree 1416 (38.0) 1416 (34.1) 238 (42.1) 305 (38.2)
Child
Prenatal blood Pb 3.67±1.47 (range 0.20–19.14) µg/dl (n=4140) 3.59±1.50 (range 1.22-14.70) µg/dl (n=574)
Sex
    Male 2146 (51.8) 5112 (51.7) 0.851 337 (58.1) 434 (51.1) 0.009
    Female 1994 (48.2) 4783 (48.3) 243 (41.9) 415 (48.9)
Preterm (livebirth <37 weeks) 
    No 3882 (93.8) 9268 (93.7) <816 559 (96.4) 796 (93.8) 0.028
    Yes 258 (6.2) 637 (6.3) 21 (3.6) 53 (6.2)
LBW (livebirth <2500 g)
    No 3867 (93.4) 9197 (92.9) 0.328 552 (95.2) 800 (94.2) 0.438
    Yes 2273 (6.6) 698 (7.1) 28 (4.8) 49 (5.8)
Pearson’s chi square test
Values are n (%)
LBW, low birth weight; BMI, body mass index
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Figure 1. Association between prenatal log10 blood lead with z-scores for BMI, height and weight in children enrolled in ALSPAC 
attending the Children in Focus (CiF) clinics (multiple imputation, n=574). (a) BMI z-score; (b) height z-score; (c) weight z-score; (d) 
MUAC; (e) waist circumference; (f) head circumference. Values are unstandardised B coefficients with 95% confidence intervals from linear 
regression models. (a)–(c) Adjusted for maternal age (years), maternal smoking (n per day), maternal education, parity (n), alcohol (n per 
day) and gestational age at sampling (weeks). (d)–(f) Adjusted for maternal age (years), maternal smoking (n per day), maternal education, 
parity (n), alcohol (n per day), gestational age at sampling (weeks), maternal BMI (kg/m2), sex and clinic age.
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Sex interactions
The p value for the association of the sex × log
10
 B-Pb 
interaction term was ≤0.2 for head circumference at 12, 31, 37, 
43 and 61 months in the imputed dataset, but was >0.2 for all 
other outcomes (Extended data, Supplementary Table 635). 
On repetition of the adjusted regression analyses for head 
circumference after stratification by sex, B coefficients were 
consistently positive for girls and negative for boys (weak asso-
ciations were evident for girls at 43 and 61 months, but not for 
boys). In all available cases, the p-value for the interaction 
was ≤0.2 for MUAC at 31 months, waist circumference at 37, 
43, 49 and 61 months, and for head circumference at 4, 37, 43, 
49 and 61 months (Extended data, Supplementary Table 635). 
On repetition of the adjusted regression analyses for head 
circumference after stratification by sex, associations were 
evident for head circumference at 43, 49 and 61 months in 
girls, but there were no associations in boys.
Sensitivity analyses
Sensitivity analysis with exclusion of preterm and/or low 
birth weight participants showed very similar results to the 
data with the cases included: there were no associations between 
prenatal B-Pb and any of the anthropometric variables in 
adjusted analyses in either the imputed dataset or among all 
available cases (Extended data, Supplementary Table 735).
Discussion
There was no evidence of any consistent associations 
between low-level prenatal exposure to lead and a range of 
anthropometric variables from 4 to 61 months in this UK cohort 
of children. A previous study of prenatal lead exposure in 
ALSPAC showed associations with birthweight, crown–heel 
length and head circumference at birth38: although the sample 
selection in the present study was different, our results suggest 
that if there were any small deficits apparent at birth, they were 
overcome in the first few months of life ex utero. This supports 
previous findings of a transient adverse effect of prenatal lead 
exposure providing exposure in childhood is low23,29. There was 
a weak positive association between prenatal B-Pb and head 
circumference in girls but not in boys (in whom the asso-
ciations tended to be negative), but not for any other 
anthropometric measure. This suggests that boys may be more 
susceptible to the adverse effects of prenatal lead exposure 
than girls, although it is difficult to explain why this would 
affect head circumference alone.
Consistent with our findings, Gardner et al.20 also found no asso-
ciations of urine lead levels from 1505 mothers in Bangladesh 
with a range of growth variables measured from birth to 
5 years of age including weight and height. Urine lead lev-
els in the Bangladeshi mothers were not reported but may be 
relatively high as lead poisoning is a major public health 
problem in that country39. Subsequent studies using cord blood 
lead concentrations rather than urine as the marker of exposure 
similarly found no relationship with stunting at 20–40 months 
of age in Bangladeshi children16.
Several other studies have provided support for the tradi-
tional hypothesis of lead exposure being associated with 
decrements in growth. In the PROGRESS study in Mexico, where 
stunting and obesity are major public health problems, there 
were negative associations of third trimester B-Pb with 
height for age and weight for age in 4–6-year-old children, but 
no association with B-Pb in the second trimester27. B-Pb in 
the second and third trimester (3.7±2.6 and 3.9±2.8 µg/dl, 
respectively) were very similar to that in the present study in 
the first trimester (3.59±1.50 µg/dl in ALSPAC-CiF). Other 
studies from South Korea and the USA have found negative 
associations of prenatal B-Pb with weight and height at 
2 years old and at 1 year old, respectively, at moderate expo-
sure concentrations (mean 1.25 and 2.8 µg/dl respectively)22,25. 
Liu et al.28 also found negative associations between maternal 
patella (but not tibia) lead and BMI z-score, waist circumfer-
ence, skinfolds thickness and body fat percentage in children in 
Mexico age 8 to 16 years.
Other studies, however, have suggested that lead exposure is 
positively associated with growth variables. A study in Korea 
including data from 280 children found positive associations 
of cord B-Pb with BMI z-scores from 18 to 27 months old, 
although not at earlier time intervals (cord B-Pb were rela-
tively low: 1.39±0.9 µg/dl for boys and 1.21±0.7 µg/dl for girls). 
This was interpreted as providing support for a hypothesis 
that perinatal lead exposure is associated with childhood obesity, 
although the mechanism is unclear. It could perhaps be related 
to the developmental origins of health and disease hypoth-
esis: if the fetus suffered stress in utero from lead exposure, 
which might restrict growth in utero, fetal programming might 
contribute to excess weight gain in early childhood if that 
stress was no longer present. However, cord B-Pb was associ-
ated with an increase rather than decrease in birth height in the 
Korean boys, but not in girls. These results are difficult to 
interpret and could be due to uncontrolled confounding or to 
chance. A similar longitudinal study in the USA including 
1442 children with anthropometric variables from preschool 
age to adolescence also found that prenatal B-Pb was associated 
with the risk of the child being overweight or obese across the 
age span in a dose–response manner, with a suggestion of effect 
mediation by insulin and leptin concentrations17. Using multilevel 
modelling of maternal perinatal blood bone lead concentrations 
to investigate the association with weight trajectories of about 
1000 Mexican children from the ELEMENT cohort, Afeiche 
et al.19 found that a 1 SD increase in patella lead was associ-
ated with 130 g decrement in weight at 5 years old in girls, but 
there was no association in boys. For tibia lead concentration, 
however, which was about 17% lower than patellar lead, there 
was no association with weight in girls. In boys, the association 
was positive at 36–60 months of age, with an 82.2 g increase 
in weight per 1 SD increase in tibia lead. The authors were 
not able to explain the difference in results from the two types 
of bone but noted that lead may accumulate more slowly in 
the tibia than the patella due to differences in vascularisation. 
Thus, the patella may reflect short-term exposure and the 
tibia longer term exposure. The mean B-Pb of these Mexican 
children across all ages (0–60 months) was 3.8±2.9 µg/dl 
(for comparison, B-Pb at 30 months old was similar at 
4.2±3.1 µg/dl in a subsample of 582 children participating 
in ALSPAC6). These findings of positive associations could 
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reflect variation in the population prevalence of overweight 
and obesity, such that high background prevalence of 
overweight and obesity might mask adverse effects of prena-
tal B-Pb on anthropometric variables. However, overweight and 
obesity were prevalent both in children in the ALSPAC cohort40 
and in the Mexican cohort41.
As the prenatal B-Pb in our study was relatively modest, it 
could be hypothesised that the exposure was too low to have any 
measurable effect on child growth. Thus, it would be 
expected that any adverse effects on growth would be magni-
fied and be detectable at high exposure levels. However, in 
a study in Yugoslavia where participants living near a smelter 
had very high levels (20.6±7.38 µg/dl) compared with control 
areas (5.6±1.99 µg/dl), there were no associations with child 
BMI or height up to age 10 years26. It may be that the effect 
of prenatal B-Pb may be moderated by subsequent exposure 
in early childhood: there was also a relatively high prenatal 
B-Pb of 7.5±1.6 µg/dl in the Cincinnati Lead Study in which 
associations of length in children between 3 and 33 months old 
were negative, but the effects were transient if subsequent child 
exposure was low23,29.
Overall, these studies do not serve as basis for strong com-
parisons or conclusions because of heterogeneity in the settings, 
and variations in participant numbers, exposure measures 
and levels, the outcomes measured, and the methods of data 
handling and statistical analyses. Even similar exposure meas-
ures, such as B-Pb, have resulted in conflicting findings, as dis-
cussed above22,25–27). Maternal bone lead is thought to be a more 
stable marker of lead exposure in pregnancy than blood concen-
trations, but results again have been conflicting19,27,28. The timing 
of exposure during pregnancy may be critical27 and thus limit 
comparisons. The length of follow-up is also important as 
the emergence of an adverse effect may be missed if the 
study length is curtailed: with the exception of a study that 
followed children up to age of 10 years26, most studies have 
included data up to the age of 5 or 6 years and some less than 
this22.
There are several strengths of this study. First, the study 
involved a relatively large number of children with measures 
of prenatal B-Pb and frequent measures of growth from 4 to 
61 months with age at clinic attendance recorded. This 
database includes a wide range of social and demographic 
information to enable the most appropriate selection of covari-
ates. Second, cross-sectional analysis by linear regression of 
prenatal lead exposure and child growth can present statistical 
difficulties because of potential violations of the assump-
tions of independence and homogeneity and because of 
multicollinearity. There is the additional problem of ranges of 
actual age at anthropometric measurements. These difficul-
ties were addressed in the present study by the use of z-scores, 
which standardises measurements across time42, and 
multiple imputation. Cross-sectional analysis also fails to 
address the problem that the number of growth measurements 
may vary from child to child, and consequent deletion of 
missing cases may lead to bias and loss of power. This was 
again overcome in the present study with multiple imputa-
tion of data. Analysis of data from all available cases did not 
change the conclusions from the multivariable regression analy-
ses with multiple imputed data. Third, the prenatal exposure 
was measured in the first half of pregnancy, providing confi-
dence in the true fetal exposure levels in contrast to studies that 
have relied on cord blood levels or other matrices such as 
hair or urine.
There are also some limitations of the study. First, although 
we were able to account for many possible confounders in 
our analyses, we may have missed some important confound-
ers while others may have been measured imperfectly. Second, 
effects on growth may have been too small, and therefore clini-
cally unimportant, to have been detected with the methods for 
anthropometric measures. Third, the role of concomitant 
exposure to other pollutants and other factors that may be asso-
ciated with growth might have the effect of masking associa-
tions (for example, polychlorinated biphenyls, 2.5 µm particulate 
matter). These measures were not included and should be 
explored further in other studies. Fourth, the time lapse between 
the exposure and the outcomes in this study means that the 
child will have experienced unknown further exposure to lead 
postnatally that was not accounted for.
Conclusion
There was no consistent evidence of associations between prena-
tal exposure to lead and growth and weight from 4 to 61 months 
in this large cohort of children in the UK. There was evidence 
for a weak positive effect of prenatal lead exposure on head 
circumference in girls at 61 months: this may have been due 
to confounding that we were unable to account for. Overall, the 
study provides no evidence for an adverse effect of low-




ALSPAC data access is through a system of managed open 
access. The steps below highlight how to apply for access to 
the data included in this research article and all other ALSPAC 
data. The datasets presented in this article are linked to 
ALSPAC project number B2116; please quote this project 
number during your application. The ALSPAC variable codes 
highlighted in the dataset descriptions can be used to specify 
required variables.
1.    Please read the ALSPAC access policy (https://www.bristol.
ac.uk/media-library/sites/alspac/documents/researchers/
data-access/ALSPAC_Access_Policy.pdf) which describes 
the process of accessing the data and samples in detail, 
and outlines the costs associated with doing so.
2.    You may also find it useful to browse our fully search-
able research proposals database (https://proposals.epi. 
bristol.ac.uk/), which lists all research projects that have 
been approved since April 2011.
3.    Please submit your research proposal for consideration 
by the ALSPAC Executive Committee. You will receive a 
Page 8 of 10
Wellcome Open Research 2020, 5:235 Last updated: 08 OCT 2020
response within 10 working days to advise you whether 
your proposal has been approved.
If you have any questions about accessing data, please email 
alspac-data@bristol.ac.uk.
The ALSPAC data management plan describes in detail the pol-
icy regarding data sharing, which is through a system of man-
aged open access. The study website also contains details of all 




Figshare: Prenatal lead exposure: associations with growth and 
anthropometry in early childhood in a UK observational birth 
cohort study: Supplementary material. https://doi.org/10.6084/
m9.figshare.1298167435.
This file contains the following extended data:
•    Supplementary Figure 1. Association between prenatal 
log
10
 blood lead with z-scores for BMI, height and weight 
in children enrolled in ALSPAC attending the Children 
in Focus (CiF) clinics (all available cases).
•    Supplementary Table 1. Number of children enrolled in 
ALSPAC-CiF clinics who also had a prenatal measure of 
blood lead and confounder data.
•    Supplementary Table 2. Equipment used for anthropomet-
ric measurements for ALSPAC-CiF clinics.
•    Supplementary Table 3. Fractions of missing data in 
ALSPAC-CiF sample (attended at least one clinic and 
with prenatal B-Pb measure) (n=574).
•    Supplementary Table 4. Characteristics of children 
enrolled in ALSPAC-CiF subsample with complete data 
on prenatal measurement of B-Pb, confounders and clinic 
data versus those with data on prenatal measurement of 
B-Pb but incomplete data on confounders and clinic data.
•    Supplementary Table 5. Anthropometry data at each time 
point in ALSPAC-CiF participants with prenatal B-Pb 
measure (multiple imputation and all available cases).
•    Supplementary Table 6. Interaction between prenatal 
B-Pb and sex in the associations between prenatal log
10
 
blood lead with MUAC, waist circumference and head 
circumference in children attending ALSPAC-CiF clin-
ics (multiple imputation and all available cases), with 
the associations for head circumference further stratified 
by sex.
•    Supplementary Table 7. Sensitivity analysis for associa-
tions between prenatal log
10
 blood lead and anthropometric 
variables in children attending ALSPAC-CiF clin-
ics (multiple imputation and all available cases) (low 
birthweight and/or preterm children excluded).
Extended data are available under the terms of the Creative 
Commons Attribution 4.0 International license (CC-BY 4.0).
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